An analysis of how longevity-focused clinical practice and prevention strategies could expand from a niche specialty into mainstream medicine over time.
Key Takeaways
- Anti-aging or longevity medicine will mainstream by focusing first on prevention
- Health systems can reduce aging-related multimorbidity and fiscal strain by investing in biomarkers
- Early integration of longevity-informed education and explainable AI risk stratification enables precise